Snyderman Nancy Lynn Md - Net Worth and Insider Trading
Snyderman Nancy Lynn Md Net Worth
The estimated net worth of Snyderman Nancy Lynn Md is at least $782,730 dollars as of 2024-12-12. Snyderman Nancy Lynn Md is the Director of Axonics Inc and owns about 7,000 shares of Axonics Inc (AXNX) stock worth over $496,860. Snyderman Nancy Lynn Md is the Director of Alkermes PLC and owns about 9,366 shares of Alkermes PLC (ALKS) stock worth over $285,663. Snyderman Nancy Lynn Md is also the Director of Lyra Therapeutics Inc and owns about 1,025 shares of Lyra Therapeutics Inc (LYRA) stock worth over $207. Details can be seen in Snyderman Nancy Lynn Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Snyderman Nancy Lynn Md has not made any transactions after 2022-03-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Snyderman Nancy Lynn Md
Snyderman Nancy Lynn Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Snyderman Nancy Lynn Md owns 4 companies in total, including Axonics Inc (AXNX) , Alkermes PLC (ALKS) , and Lyra Therapeutics Inc (LYRA) among others .
Click here to see the complete history of Snyderman Nancy Lynn Md’s form 4 insider trades.
Insider Ownership Summary of Snyderman Nancy Lynn Md
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AXNX | Axonics Inc | 2019-06-27 | director |
ALKS | Alkermes PLC | 2022-03-04 | director |
LYRA | Lyra Therapeutics Inc | 2020-12-16 | director |
2021-09-09 | director |
Snyderman Nancy Lynn Md Latest Holdings Summary
Snyderman Nancy Lynn Md currently owns a total of 3 stocks. Among these stocks, Snyderman Nancy Lynn Md owns 7,000 shares of Axonics Inc (AXNX) as of June 27, 2019, with a value of $496,860 and a weighting of 63.48%. Snyderman Nancy Lynn Md owns 9,366 shares of Alkermes PLC (ALKS) as of March 4, 2022, with a value of $285,663 and a weighting of 36.5%. Snyderman Nancy Lynn Md also owns 1,025 shares of Lyra Therapeutics Inc (LYRA) as of December 16, 2020, with a value of $207 and a weighting of 0.03%.
Latest Holdings of Snyderman Nancy Lynn Md
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AXNX | Axonics Inc | 2019-06-27 | 7,000 | 70.98 | 496,860 |
ALKS | Alkermes PLC | 2022-03-04 | 9,366 | 30.50 | 285,663 |
LYRA | Lyra Therapeutics Inc | 2020-12-16 | 1,025 | 0.20 | 207 |
Holding Weightings of Snyderman Nancy Lynn Md
Snyderman Nancy Lynn Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Snyderman Nancy Lynn Md has made a total of 0 transactions in Axonics Inc (AXNX) over the past 5 years. The most-recent trade in Axonics Inc is the acquisition of 2,000 shares on June 27, 2019, which cost Snyderman Nancy Lynn Md around $74,240.
According to the SEC Form 4 filings, Snyderman Nancy Lynn Md has made a total of 1 transactions in Alkermes PLC (ALKS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alkermes PLC is the acquisition of 427 shares on March 4, 2022, which cost Snyderman Nancy Lynn Md around $10,005.
According to the SEC Form 4 filings, Snyderman Nancy Lynn Md has made a total of 1 transactions in Lyra Therapeutics Inc (LYRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lyra Therapeutics Inc is the acquisition of 1,025 shares on December 16, 2020, which cost Snyderman Nancy Lynn Md around $9,963.
Insider Trading History of Snyderman Nancy Lynn Md
- 1
Snyderman Nancy Lynn Md Trading Performance
GuruFocus tracks the stock performance after each of Snyderman Nancy Lynn Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Snyderman Nancy Lynn Md is 14.88%. GuruFocus also compares Snyderman Nancy Lynn Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Snyderman Nancy Lynn Md within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Snyderman Nancy Lynn Md's insider trading performs compared to the benchmark.
Performance of Snyderman Nancy Lynn Md
Snyderman Nancy Lynn Md Ownership Network
Ownership Network List of Snyderman Nancy Lynn Md
Ownership Network Relation of Snyderman Nancy Lynn Md
Snyderman Nancy Lynn Md Owned Company Details
What does Axonics Inc do?
Who are the key executives at Axonics Inc?
Snyderman Nancy Lynn Md is the director of Axonics Inc. Other key executives at Axonics Inc include Chief Financial Officer Kari Leigh Keese , Chief Medical Officer Karen Noblett , and director & Chief Executive Officer Raymond W Cohen .
Axonics Inc (AXNX) Insider Trades Summary
Over the past 18 months, Snyderman Nancy Lynn Md made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 35,287 shares made by Karen Noblett , a net sale of 32,884 shares made by Ford Alfred J Jr , and a net sale of 6,450 shares made by Kari Leigh Keese .
In summary, during the past 3 months, insiders sold 2,961 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 2,961 shares. During the past 18 months, 133,356 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,356 shares.
Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axonics Inc Insider Transactions
Snyderman Nancy Lynn Md Mailing Address
Above is the net worth, insider trading, and ownership report for Snyderman Nancy Lynn Md. You might contact Snyderman Nancy Lynn Md via mailing address: 37 Pheasant Hill Road, Princeton Nj 08540.